NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. RAPAMUNE® Sirolimus Oral Solution Consumer Medicine Information
Continue reading »
Sprycel
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SPRYCEL® (Spry-sell) Dasatinib (duh-sat-in-ib) Consumer Medicine Information
Continue reading »Does Oral Bacteria Affect Colon Cancer?
The colon is a part of the digestive tract whose primary function is the absorption of water and nutrients from
Continue reading »DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19
RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board
Continue reading »Opdivo
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OPDIVO CMI _V17.0 (op-DEE-voh) Nivolumab (nee-vol-u-mab) Consumer
Continue reading »Torisel
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TORISEL® Temsirolimus Concentrate for Injection Consumer Medicine
Continue reading »Investigating the Molecular Mechanisms of Cancer
Cancer is one of the leading causes of human mortality worldwide. Even though leaps have been made in the fight
Continue reading »Novel treatment avenue for resistant cancers: Removing SORLA protein from drug-resistant HER2-positive cancer cell lines
SORLA is a protein trafficking receptor that has been mainly studied in neurons, but it also plays a role in
Continue reading »Childhood cancer survivors are not more likely to terminate their pregnancies
Female childhood cancer survivors face a lower likelihood of becoming pregnant than women in the general population, but once pregnant,
Continue reading »Timing and intensity of oral sex may affect risk of oropharyngeal cancer
Human papillomavirus (HPV) can infect the mouth and throat to cause cancers of the oropharynx. A new study published early
Continue reading »